CUFinder

Christopher P. Cannon

Christopher P. Cannon

Harvard University

H-index: 189

North America-United States

Contact Christopher P. Cannon

About Christopher P. Cannon

Christopher P. Cannon, With an exceptional h-index of 189 and a recent h-index of 107 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Cardiology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trial

Randomized Evaluation of a Remote Management Program to Improve Guideline-directed Medical Therapy: The Diabetes Remote Intervention to Improve Use of Evidence-based …

CONTEMPORARY ANTI-OBESITY PHARMACOTHERAPY PRESCRIBING PATTERNS IN A LARGE US TERTIARY HEALTHCARE SYSTEM, 2018-2022

LIPOPROTEIN (A) AS A CARDIOVASCULAR RISK FACTOR AMONG PATIENTS WITH AND WITHOUT DIABETES MELLITUS: THE MASS GENERAL BRIGHAM LP (A) REGISTRY

THE ASSOCIATION OF IMMUNE-MEDIATED INFLAMMATORY DISEASE AND LIPOPROTEIN (A) WITH MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG INDIVIDUALS WITH AND WITHOUT BASELINE …

Concurrent Evaluation of hsTnI and hsTnT and Their Associations with Cardiovascular Events in 37,886 Patients with Stable Atherosclerotic Cardiovascular Disease

LONG-TERM BLOOD PRESSURE TRENDS FOLLOWING A REMOTE HYPERTENSION INTERVENTION

Christopher P. Cannon Information

University

Position

Professor of Medicine, Harvard Medical School, Brigham and Women's Hospital

Citations(all)

194201

Citations(since 2020)

60426

Cited By

149464

hIndex(all)

189

hIndex(since 2020)

107

i10Index(all)

859

i10Index(since 2020)

517

Email

University Profile Page

Google Scholar

Christopher P. Cannon Skills & Research Interests

Cardiology

Top articles of Christopher P. Cannon

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

The Lancet Diabetes & Endocrinology

2024/5/1

David Preiss
David Preiss

H-Index: 40

Kate Wilson
Kate Wilson

H-Index: 9

Alistair J Roddick
Alistair J Roddick

H-Index: 5

Robert Clarke
Robert Clarke

H-Index: 38

Shinya Goto
Shinya Goto

H-Index: 51

Naveed Sattar
Naveed Sattar

H-Index: 125

Colin Baigent
Colin Baigent

H-Index: 74

Elizabeth Barnes
Elizabeth Barnes

H-Index: 15

James De Lemos
James De Lemos

H-Index: 74

Marcus Flather
Marcus Flather

H-Index: 63

Ian Ford
Ian Ford

H-Index: 16

David Gordon
David Gordon

H-Index: 15

Ajay Gupta
Ajay Gupta

H-Index: 34

Sharon Kean
Sharon Kean

H-Index: 15

Patricia Kearney
Patricia Kearney

H-Index: 48

Martin Landray
Martin Landray

H-Index: 44

Peter Sever
Peter Sever

H-Index: 70

John Shaw
John Shaw

H-Index: 22

James Shepherd
James Shepherd

H-Index: 8

John Varigos
John Varigos

H-Index: 10

Christoph Wanner
Christoph Wanner

H-Index: 12

Stephen Wiviott
Stephen Wiviott

H-Index: 65

Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trial

European journal of heart failure

2024/4/17

Randomized Evaluation of a Remote Management Program to Improve Guideline-directed Medical Therapy: The Diabetes Remote Intervention to Improve Use of Evidence-based …

Circulation

2024/4/7

CONTEMPORARY ANTI-OBESITY PHARMACOTHERAPY PRESCRIBING PATTERNS IN A LARGE US TERTIARY HEALTHCARE SYSTEM, 2018-2022

Journal of the American College of Cardiology

2024/4/2

Sanjay Kumar
Sanjay Kumar

H-Index: 23

LIPOPROTEIN (A) AS A CARDIOVASCULAR RISK FACTOR AMONG PATIENTS WITH AND WITHOUT DIABETES MELLITUS: THE MASS GENERAL BRIGHAM LP (A) REGISTRY

Journal of the American College of Cardiology

2024/4/2

Adam N Berman
Adam N Berman

H-Index: 4

David Biery
David Biery

H-Index: 8

Sanjay Divakaran
Sanjay Divakaran

H-Index: 12

Ron Blankstein
Ron Blankstein

H-Index: 64

THE ASSOCIATION OF IMMUNE-MEDIATED INFLAMMATORY DISEASE AND LIPOPROTEIN (A) WITH MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG INDIVIDUALS WITH AND WITHOUT BASELINE …

Journal of the American College of Cardiology

2024/4/2

Adam N Berman
Adam N Berman

H-Index: 4

Ron Blankstein
Ron Blankstein

H-Index: 64

Concurrent Evaluation of hsTnI and hsTnT and Their Associations with Cardiovascular Events in 37,886 Patients with Stable Atherosclerotic Cardiovascular Disease

Journal of the American College of Cardiology

2024/4/2

Petr Jarolim
Petr Jarolim

H-Index: 39

Stephen Wiviott
Stephen Wiviott

H-Index: 65

LONG-TERM BLOOD PRESSURE TRENDS FOLLOWING A REMOTE HYPERTENSION INTERVENTION

Journal of the American College of Cardiology

2024/4/2

Sanjay Kumar
Sanjay Kumar

H-Index: 23

SUCCESS OF A REMOTELY DELIVERED LIPID PROGRAM IN ACHIEVING TARGET LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS

Journal of the American College of Cardiology

2024/4/2

Sanjay Kumar
Sanjay Kumar

H-Index: 23

REAL-WORLD APPLICATION OF SELECT TRIAL CRITERIA IN A LARGE URBAN AND SUBURBAN HEALTH SYSTEM

Journal of the American College of Cardiology

2024/4/2

Sanjay Kumar
Sanjay Kumar

H-Index: 23

The year in cardiovascular medicine 2023: the top 10 papers in diabetes and metabolic disorders

2024/2/14

Lipoprotein (a) and major adverse cardiovascular events in patients with or without baseline atherosclerotic cardiovascular disease

Journal of the American College of Cardiology

2024/3/5

Adam N Berman
Adam N Berman

H-Index: 4

Sanjay Divakaran
Sanjay Divakaran

H-Index: 12

Ron Blankstein
Ron Blankstein

H-Index: 64

Methods, rationale, and design for a remote pharmacist and navigator-driven disease management program to improve guideline-directed medical therapy in patients with type 2 …

Primary Care Diabetes

2024/2/1

How Generalizable Is The Soloist-whf Trial In ‘Real World’Patients With Diabetes Admitted With Heart Failure? Results From A Large Us Integrated Health System

Journal of Cardiac Failure

2024/1/1

HEART FAILURE OUTCOMES CAPTURED BY ADVERSE EVENT REPORTING IN PARTICIPANTS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: OBSERVATIONS FROM THE VERTIS CV TRIAL

Journal of the American College of Cardiology

2023/3/7

Ambarish Pandey
Ambarish Pandey

H-Index: 39

Francesco Cosentino
Francesco Cosentino

H-Index: 1

Jie Liu
Jie Liu

H-Index: 2

Cardiovascular outcomes in patients with coronary artery disease and elevated lipoprotein (a): implications for the OCEAN (a)-outcomes trial population

European Heart Journal Open

2023/7

Adam N Berman
Adam N Berman

H-Index: 4

Christopher Cannon
Christopher Cannon

H-Index: 3

Ron Blankstein
Ron Blankstein

H-Index: 64

Using Electronic Health Record Data to Identify and Prioritize Patients With Heart Failure With Reduced Ejection Fraction for a Remote Medication Optimization Program

Circulation

2023/11/7

Intensity of Lipid-Lowering Therapy Among Patients With Polyvascular Disease

JAMA Network Open

2023/3/1

In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show?

2023/7

IDF2022-0796 Sustained weight loss with ertugliflozin in patients with T2D and atherosclerotic cardiovascular disease in VERTIS CV

Diabetes Research and Clinical Practice

2023/3/1

See List of Professors in Christopher P. Cannon University(Harvard University)